Macrophage heterogeneity and efferocytosis: Beyond the M1/M2 dichotomy
Open accessThe claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the liver, single-cell technologies have revealed a far more intricate landscape of coexisting, specialized macrophage subsets beyond the M1/M2 binary classification.
“This is particularly evident in the liver, where single-cell technologies have revealed a far more intricate landscape of coexisting, specialized subsets beyond this binary classification (12, 13).”
From Macrophage duality in liver diseases: heterogeneity, plasticity, and the quest for precision therapeutics (2026) · cites this paper as [12]
The main text (page not provided) says single-cell technologies have revealed macrophage heterogeneity beyond the M1/M2 dichotomy. Its examples concern human atherosclerotic plaques and activated primary human macrophages, not the liver; the liver-specific part of the claim is unsupported by this source. (LLM, conf=0.86)
Experimental — accuracy not yet measuredThe traditional M1/M2 polarization framework is an oversimplification that fails to capture the full spectrum of macrophage phenotypes observed in vivo.
“While the traditional M1/M2 polarization framework has been invaluable for conceptualizing macrophage functional duality, it is increasingly recognized as an oversimplification that fails to capture the full spectrum of phenotypes observed in vivo.”
From Macrophage duality in liver diseases: heterogeneity, plasticity, and the quest for precision therapeutics (2026) · cites this paper as [12]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Macrophage activation and polarization: nomenclature and experimental guidelines
Murray, P. J., Allen, J. E., Biswas, S. K., Fisher, E. A., Gilroy, D. W., Goerdt, S., Gordon, S., Hamilton, J. A., Ivashkiv, L. B., Lawrence, T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.008 · Cited by 6,337 · see citing works
M-1/M-2 Macrophages and the Th1/Th2 Paradigm
Mills, C. D., Kincaid, K., Alt, J. M., Heilman, M. J., & Hill, A. M. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.12.6166 · Cited by 3,287 · see citing works
Single-cell immune landscape of human atherosclerotic plaques
Fernandez, D. M., Rahman, A. H., Fernandez, N. F., Chudnovskiy, A., Amir, E.-A. D., Amadori, L., Khan, N. S., Wong, C. K., Shamailova, R., Hill, C. A., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0590-4 · Cited by 970 · see citing works
CD47-blocking antibodies restore phagocytosis and prevent atherosclerosis
Kojima, Y., Volkmer, J.-P., McKenna, K., Civelek, M., Lusis, A. J., Miller, C. L., Direnzo, D., Nanda, V., Ye, J., Connolly, A. J., et al. (2016) · Nature · doi:10.1038/nature18935 · Cited by 683 · see citing works
Macrophages in Atherosclerosis Regression
Barrett, T. J. (2019) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.119.312802 · Cited by 633 · see citing works
Efferocytosis induces macrophage proliferation to help resolve tissue injury
Gerlach, B. D., Ampomah, P. B., Yurdagul, A., Liu, C., Lauring, M. C., Wang, X., Kasikara, C., Kong, N., Shi, J., Tao, W., et al. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.10.015 · Cited by 360 · see citing works
Nepal, S., Tiruppathì, C., Tsukasaki, Y., Farahany, J., Mittal, M., Rehman, J., Prockop, D. J., & Malik, A. B. (2019) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1821601116 · Cited by 136 · see citing works
CD147 Sparks Atherosclerosis by Driving M1 Phenotype and Impairing Efferocytosis
Lv, J., Wang, H., Zhang, C., Zhang, T.-J., Wei, H.-L., Liu, Z., Ma, Y.-H., Yang, Z. P., He, Q., Wang, L.-J., et al. (2024) · Circulation Research · doi:10.1161/circresaha.123.323223 · Cited by 98 · see citing works
Atherosclerosis is a major human killer and non-resolving inflammation is a prime suspect
Fredman, G., & MacNamara, K. C. (2021) · Cardiovascular Research · doi:10.1093/cvr/cvab309 · Cited by 52 · see citing works
Idrus, F. N. M., Ahmad, N. S., Hoe, C. H., Azlan, M., Norfuad, F. A., Yusof, Z., Isa, W. Y. H. W., Ali, A. A. M., & Yvonne-Τee, G. B. (2021) · BMC Immunology · doi:10.1186/s12865-021-00410-2 · Cited by 31 · see citing works
Decano, J. L., Maiorino, E., Matamalas, J. T., Chelvanambi, S., Tiemeijer, B. M., Yanagihara, Y., Mukai, S., Jha, P. K., Pestana, D. V. S., D'Souza, E. D. A., et al. (2023) · Circulation · doi:10.1161/circulationaha.123.064794 · Cited by 29 · see citing works
Self-citationMacrophage Heterogeneity Complicates Reversal of Calcification in Cardiovascular Tissues
Rogers, M. A., Aikawa, M., & Aïkawa, E. (2017) · Circulation Research · doi:10.1161/circresaha.117.311219 · Cited by 28 · see citing works
Self-citationDecano, J. L., & Aikawa, M. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00097 · Cited by 28 · see citing works
Self-citationHolden, R. M., Hétu, M., Li, T. Y., Ward, E., Couture, L., Herr, J. E., Christilaw, E., Adams, M. A., & Johri, A. M. (2018) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2018.11.018 · Cited by 14 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Macrophage polarization in sepsis: Emerging role and clinical application prospect
Hou, F., Mi, J. H., Wang, Q., Tao, Y. L., bin Guo, S., Ran, G. H., & Wang, J. C. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113715 · Cited by 36 · see citing works
Vascular inflammation in chronic kidney disease: the role of uremic toxins in macrophage activation
Jha, P. K., Nakano, T., Itto, L. Y. U., Barbeiro, M. C., Lupieri, A., Aikawa, E. R., & Aikawa, M. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1574489 · Cited by 29 · see citing works
Self-citationMitochondrial dynamics and metabolism in macrophages for cardiovascular disease: A review
Zhong, Y.-L., Xu, C.-Q., Li, J., Liang, Z., Wang, M., Ma, C., Jia, C., Cao, Y., & Chen, J. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.156620 · Cited by 25 · see citing works
Chen, D., Feng, Y.-Y., Wang, H., Lu, C., Liu, D.-Z., Chen, G., Xue, Y., Na, N., & Huang, F. (2025) · Molecular Medicine · doi:10.1186/s10020-025-01150-4 · Cited by 25 · see citing works
Xia, L., Li, C., Zhao, J., Sun, Q., & Mao, X. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.156150 · Cited by 22 · see citing works
Precision cardiovascular medicine: shifting the innovation paradigm
Aikawa, M., Sonawane, A. R., Chelvanambi, S., Asano, T., Halu, A., Matamalas, J. T., Singh, S. A., Uchida, S., Aïkawa, E., Arenas, À., et al. (2025) · Frontiers in Science · doi:10.3389/fsci.2025.1474469 · Cited by 22 · see citing works
Self-citationWang, Y., Mao, J., Wang, Y., Wang, R., Duan, D., Liu, Z., Hu, X., Yu, Z., & Shi, X. (2025) · Journal of Advanced Research · doi:10.1016/j.jare.2025.11.057 · Cited by 20 · see citing works
Efferocytosis and Bone Dynamics
Batoon, L., Hawse, J. R., McCauley, L. K., Weivoda, M. M., & Roca, H. (2024) · Current Osteoporosis Reports · doi:10.1007/s11914-024-00878-y · Cited by 15 · see citing works
Macrophages: emerging targets for ulcerative colitis
Chen, S., Qin, Z., Lin, X., Zhou, S., Xu, Y., & Zhu, Y. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1623491 · Cited by 13 · see citing works
Role of macrophages in vascular calcification: From the perspective of homeostasis
Dong, R., Ji, Z., Wang, M., & Ma, G. (2024) · International Immunopharmacology · doi:10.1016/j.intimp.2024.113635 · Cited by 11 · see citing works
Zhang, F., Zhang, A., Meng, T., Liu, X., Yang, C., Liang, C., & Zhang, M. (2026) · Redox Biology · doi:10.1016/j.redox.2026.104042 · Cited by 9 · see citing works
MicroRNA-26b−/− augments atherosclerosis, while mimic-loaded nanoparticles reduce atherogenesis
Peters, L. J. F., Bidzhekov, K., Bonnin-Marquez, A., Sundararaman, S. S., Huchzermeier, R., Maas, S. L., Abschlag, K., Jans, A., Lin, C., Haberbosch, M., et al. (2025) · Cardiovascular Research · doi:10.1093/cvr/cvaf234 · Cited by 8 · see citing works
Exploitable mechanisms of antibody and CAR mediated macrophage cytotoxicity
Liu, T., Zhang, M., Farsh, T., Li, H., Kishishita, A., Barpanda, A., Leung, S. G., Zhu, J., Jung, H., Hua, J. T., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60745-x · Cited by 6 · see citing works
Chen, J., Xu, C., Zhang, S., Sui, H., Fang, K., Li, S. L., Yang, R., Yang, C., Shao, D., Zheng, Q., et al. (2025) · Biomaterials · doi:10.1016/j.biomaterials.2025.123773 · Cited by 6 · see citing works
Xu, X., Liu, C., Bo, J., Wang, H., Zhang, Y., Xu, Y., Fu, J., Pi, J., & Wang, H. (2026) · Journal of Advanced Research · doi:10.1016/j.jare.2026.01.005 · Cited by 5 · see citing works
Su, Y., Wang, H., Liu, H., & Tang, Y. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115899 · Cited by 4 · see citing works
OnabotulinumtoxinA alters pro- and anti-inflammatory dural macrophage response to CSD in female mice
Schain, A. J., Fajardo, D. D., Strassman, A. M., Kulkarni, S., Broide, R. S., Brideau-Andersen, A. D., Adams, A. M., Brin, M. F., & Burstein, R. (2025) · Cephalalgia · doi:10.1177/03331024251378730 · Cited by 4 · see citing works
Liu, T., Zhang, W., Bao, W., Wang, X., Zhang, F., Guo, J., & Li, M. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.115526 · Cited by 3 · see citing works
Liu, J., Wen, Z., Tang, S., Wu, J., Bi, X., Yang, Y., & Huang, C. (2026) · Toxins · doi:10.3390/toxins18040155 · Cited by 3 · see citing works
Yu, C., Feng, Q., Liao, Y., Tan, M., Zhao, Y., Chen, L., Zhang, W., Lin, C., Zeng, R., Al-Smadi, F., et al. (2026) · Bioactive Materials · doi:10.1016/j.bioactmat.2026.04.009 · Cited by 3 · see citing works
Immunological characteristics and functions of macrophages in Mycobacterium leprae infection
Zhang, X., Jiang, H., Liu, W., & Wang, H. (2025) · BMC Immunology · doi:10.1186/s12865-025-00759-8 · Cited by 2 · see citing works
Li, Q., Kong, H., Li, Q., Chen, T., Chen, L., Wang, F., Zhang, X., Wu, Y., Zhu, Y., Geng, Z., et al. (2026) · International Immunopharmacology · doi:10.1016/j.intimp.2026.116344 · Cited by 2 · see citing works
Sequential Macrophage Polarization Mediated by a Biphasic Cold Plasma Pen for Oral Ulcer Therapy
Gong, X., Yu, D., Yang, H., Wang, H., Bai, Y., Zheng, Z., & Chen, W. (2026) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5c25563 · Cited by 2 · see citing works
Chen, L., Chen, Y., Zhao, M., Yang, X., Sutte, K., Lu, M., Chen, J., Zheng, X., Yang, D., & Liu, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1814879 · Cited by 1 · see citing works
Zhang, M., Zhang, B., Tao, Q.-Q., Wang, X.-Y., Guan, X.-X., Dong, Z., Guo, X., Qi, W., Cheng, W.-Z., Zhang, X., et al. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.177867 · Cited by 1 · see citing works
Zhang, Y., Ding, Z., Wang, X., Shen, J., Chen, L., Chen, L., Chen, W., Zhang, Y., & Zhang, Y. (2026) · Chinese Medicine · doi:10.1186/s13020-026-01373-5 · Cited by 1 · see citing works
Defective efferocytosis in diabetes: molecular mechanisms and emerging therapeutic strategies
Lei, Y., Tang, M., Deng, H., Li, Y., Wu, J., Luo, L., Mou, Y., 吴千石, Li, Q., Xu, Y., et al. (2026) · Inflammation Research · doi:10.1007/s00011-026-02302-w · Cited by 1 · see citing works
PDE3A2 modRNA Fine-Tunes Nuclear cAMP Microdomains and Reverses Pathological Cardiac HypertrophyPreprint
Xiang, W., Lian, M., Guan, Q., Sun, X., Li, S., Lu, H., Qin, G., Xiang, Y. K., Ni, H., & Wang, Y. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2025.09.30.679675
Zhuang, Z., Liu, Z., Su, H., Sun, W., Zhu, Q., Xu, J., Fang, J., Li, L., Shen, D., Zou, X., et al. (2025) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2025.12.12.693855
Yamaguchi, M., Takagi, K., Takahashi, M., Sato, A., Yamazaki, Y., Miyashita, M., & Suzuki, T. (2026) · Breast Cancer · doi:10.1007/s12282-026-01825-8
Liu, X., & Liu, R. (2026) · Frontiers in Physiology · doi:10.3389/fphys.2026.1768672
Sun, Q., Huang, J., Gu, Y., Liu, S., Cheng, Y., & Zhu, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1799793
Sun, H., Feng, Y., Shao, R., Liu, W., Ren, Z., Hou, X., & He, B. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1785241
Targeting CD3L1-NRP2 disarms myeloid-driven tumor immune evasion
Deng, S., Fang, Y., Xue, J., Wang, R., Zhou, X., Li, C., Li, N., Wang, S., Zhang, Y., Wang, H., et al. (2026) · EMBO Molecular Medicine · doi:10.1038/s44321-026-00451-3
Chen, Z., Wang, J., Jiang, Y., Qin, Z., Wang, N., & Zeng, B. (2026) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2026.111523
Yadav, S., Rajagopal, K., Varadarajan, S., Nagarkoti, S., Das, A., Spears, S. K., Veeranan‐Karmegam, R., Fukai, T., & Ushio‐Fukai, M. (2026) · Antioxidants · doi:10.3390/antiox15060768
Xiang, W., Song, X., Xian, X., Zhou, H., Xu, B., Zhou, L., Yang, D., & Zheng, Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1863507
Quan, X., Ji, L., He, T., Liu, J., Shi, L., & Liu, L. (2026) · Journal of Digestive Diseases · doi:10.1111/1751-2980.70060
Li, Q., Chen, S., Wu, J., Tang, S., Wen, Z., Han, X., Bi, X., Huang, C., & Liu, J. (2026) · Toxicon · doi:10.1016/j.toxicon.2026.109226
Chen, H.-L., Wang, R., Tao, W.-J., Zhang, W., Gao, Y.-L., & Cheng, X.-B. (2026) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2026.112265
Macrophage-associated noncoding RNAs in atherosclerosis and chronic kidney disease
Jha, P. K., Nascimento, C. B., Lupieri, A., Aikawa, E. R., & Aikawa, M. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1884576
Self-citationMeta-inflammation through the lens of macrophage programming and nutrient-sensing ghrelin signaling
Han, H. W., Kim, D. M., Eshghjoo, S., Xu, C., Liu, Z., Patil, B. S., Guo, S., & Sun, Y. (2026) · Immunometabolism · doi:10.1097/in9.0000000000000088
Liu, J., Chen, S., Wu, J., Tang, S., Wen, Z., Bi, X., Yang, Y., & Huang, C. (2026) · Journal of Lipid Research · doi:10.1016/j.jlr.2026.101123
Yalçınkaya, M., Hsu, C.-C., Li, L., Wang, R., Ngai, D., Vela, P. S., Fernández-Maestre, I., Olszewska, M., Liu, W., Chen, M., et al. (2026) · Circulation · doi:10.1161/circulationaha.126.080527
Liu, Y., Wu, Z., Huang, B., Ye, W., Xu, S., He, W., Lan, Y., Xiao, C., Qin, C., Gao, W., et al. (2026) · iScience · doi:10.1016/j.isci.2026.117439
- Authors
- Kumar Jha, P., Aikawa, M., & Aikawa, E.
- Affiliations
- Center for Excellence in Vascular Biology (P.K.J., M.A., E.A.), Brigham and Women’s Hospital, Harvard Medical School, Boston.
- Brigham and Women's Hospital (US)
- Corresponding author
- Aikawa, Elena
- Venue
- Circulation Research
- Published
- 2024-01-19
- Volume
- 134
- Issue
- 2
- Pages
- 186-188
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- PMC
- PMC10798221
- OpenAlex
- W4390967697
- Cited by
- 45
- References
- 14
- Citations by year
- 2026: 25 · 2025: 16 · 2024: 4
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Circulation Research (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Heart, Lung, and Blood Institute (R01HL126901, R01HL149302, R01HL136431, R01HL147095, R01HL141917, OT2HL161847)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Phagocytosis and Immune Regulation
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Life Sciences › Immunology and Microbiology › Immunology › Atherosclerosis and Cardiovascular Diseases
- Keywords
- macrophage heterogeneity, efferocytosis, macrophage polarization, macrophage function
- MeSH terms
- Efferocytosis, Humans, Inflammation, Macrophages, Phagocytosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review